Literature DB >> 20113761

The national clinical audit of falls and bone health-secondary prevention of falls and fractures: a physiotherapy perspective.

Victoria Goodwin1, Finbarr C Martin, Janet Husk, Derek Lowe, Robert Grant, Jonathan Potter.   

Abstract

OBJECTIVE: To establish current physiotherapy practice in the secondary management of falls and fragility fractures compared with national guidance.
DESIGN: Web-based national clinical audit. PARTICIPANTS: Acute trusts (n=157) and primary care trusts (n=146) in England, Wales and Northern Ireland.
RESULTS: Data were collected on 5642 patients with non-hip fragility fractures and 3184 patients with a hip fracture. Those patients who were bedbound or who declined assessment or rehabilitation were excluded from the analysis. Results indicate that of those with non-hip fractures, 28% received a gait and balance assessment, 22% participated in an exercise programme, and 3% were shown how to get up from the floor. For those with a hip fracture, the results were 68%, 44% and 7%, respectively.
CONCLUSIONS: Physiotherapists have a significant role to play in the secondary prevention of falls and fractures. However, along with managers and professional bodies, more must be done to ensure that clinical practice reflects the evidence base and professional standards.

Entities:  

Mesh:

Year:  2009        PMID: 20113761     DOI: 10.1016/j.physio.2009.07.003

Source DB:  PubMed          Journal:  Physiotherapy        ISSN: 0031-9406            Impact factor:   3.358


  2 in total

Review 1.  Community-based health efforts for the prevention of falls in the elderly.

Authors:  Alan Hanley; Carmel Silke; John Murphy
Journal:  Clin Interv Aging       Date:  2010-12-20       Impact factor: 4.458

2.  Knowledge, skills and attitudes of older people and staff about getting up from the floor following a fall: a qualitative investigation.

Authors:  Dawn R Swancutt; Suzy V Hope; Benjamin P Kent; Maria Robinson; Victoria A Goodwin
Journal:  BMC Geriatr       Date:  2020-10-06       Impact factor: 3.921

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.